Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ALTEROLA BIOTECH, INC.

(ABTI)
SummaryQuotesChartsNewsCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Alterola Biotech, Inc. Announces Executive Changes

10/05/2021 | 05:09pm EST

Alterola Biotech, Inc. announced that on September 28, 2021, the board of directors and shareholders removed Larson Elsmore as CFO. On the same date, the board of directors appointed Timothy Paul Rogers as Interim CFO.


ę S&P Capital IQ 2021
All news about ALTEROLA BIOTECH, INC.
11/16Alterola Biotech, Inc. signed an agreement to acquire Assets from C2 Wellness Corporati..
CI
11/15ALTEROLA BIOTECH INC. Management's Discussion and Analysis of Financial Condition and ..
AQ
10/05ALTEROLA BIOTECH : Board Replaces Outgoing CFO Larson Elsmore With Timothy Rogers as Inter..
MT
10/05ALTEROLA BIOTECH INC. : Change in Directors or Principal Officers (form 8-K)
AQ
10/05Alterola Biotech, Inc. Announces Executive Changes
CI
10/05Alterola Biotech, Inc. Announces Executive Changes
CI
09/23Alterola Biotech, Inc. Confirms Appointment of Hunter Land to the Board
CI
08/19ALTEROLA BIOTECH : Management's Discussion and Analysis of Financial Condition and Results..
AQ
08/02ALTEROLA BIOTECH : acquires ABTI pharma ltd
AQ
06/21ALTEROLA BIOTECH INC. : Change in Directors or Principal Officers (form 8-K)
AQ
More news
Financials (USD)
Sales 2021 - - -
Net income 2021 -0,34 M - -
Net Debt 2021 0,03 M - -
P/E ratio 2021 -
Yield 2021 -
Capitalization 244 M 244 M -
EV / Sales 2020
EV / Sales 2021 -
Nbr of Employees -
Free-Float 15,0%
Chart ALTEROLA BIOTECH, INC.
Duration : Period :
Alterola Biotech, Inc. Technical Analysis Chart | ABTI | US02152V1035 | MarketScreener
Income Statement Evolution
Managers and Directors
Seamus McAuley Chief Executive Officer & Secretary
Timothy Paul Rogers Chairman & Chief Financial Officer
Colin Stott Chief Operating Officer & Director
Dominic Schiller Director
Daniel S. Reshef Director
Sector and Competitors
1st jan.Capi. (M$)
ALTEROLA BIOTECH, INC.-0.03%244
GILEAD SCIENCES, INC.20.61%88 146
BIONTECH SE326.89%84 049
REGENERON PHARMACEUTICALS33.17%67 266
WUXI APPTEC CO., LTD.24.40%64 416
VERTEX PHARMACEUTICALS-22.32%46 678